Karen Ivinson

Program for Appropriate Technology in Health

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial”.

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00273-0

N/A

2.6DataRank · unranked

72 citations

Daniel Ansong, Simon Kariuki, Samuel Adjei, Anne Bollaerts, Christian F. Ockenhouse +35 more

Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial

The Lancet Global Health(2025)10.1016/s2214-109x(25)00272-4

N/A

0.270DataRank · unranked

3 citations

Simon Kariuki, Cynthia Lee, Robin Fabre, Dennis K Bii, Samuel Adjei +30 more